萬邦德(002082.SZ):擬停止上海興棟鋁經貿發展的經營業務
格隆匯 9 月 13日丨萬邦德(002082.SZ)公佈,鑑於公司子公司上海興棟鋁經貿發展有限公司(“上海興棟鋁”)所從事的貿易業務佔用資金規模大,毛利率低,資本回報率低。公司擬停止上海興棟鋁經貿發展有限公司經營業務,並在股東大會審議通過後逐步辦理清算註銷事宜。
公司看好醫療業務的發展前景,在現有條件下,集中精力和資源做強做大醫藥製造和醫療器械業務成為較優的選擇。公司根據戰略發展規劃,將資源聚焦醫藥製造和醫療器械業務發展。
而上海興棟鋁所從事的有色金屬貿易業務毛利率低,資金佔用大,資本回報率低,因此公司擬停止上海興棟鋁業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.